PURPOSE OF REVIEW: Remarkable progress has been achieved over the past 2 years in understanding the cellular actions of renalase, its pathophysiology and potential therapeutic utility. RECENT FINDINGS: There has been a paradigm shift in our thinking about the mechanisms underlying the cellular actions of renalase. We now understand that, independent of its enzymatic properties, renalase functions as a signaling molecule, a cytokine that interacts with a yet-to-be identified plasma membrane receptor(s) to activate protein kinase B and the mitogen-activated protein kinase pathway. These signaling properties are critical to its cytoprotective effects. New information regarding renalase's enzymatic function as an α-nicotinamide adenine dinucleotide oxidase/anomerase will be reviewed. Lastly, we will discuss the association of certain single nucleotide polymorphisms in the renalase gene with type 1 diabetes and with ischemic stroke, and the clinical implications of these findings. SUMMARY: The consistent association of renalase single nucleotide polymorphisms and the development of type 1 diabetes is a great interest particularly because we now understand that renalase functions as a cytokine. Future work on renalase should focus on exploring the identity of its receptor(s), and its potential role as an immune modulator.
PURPOSE OF REVIEW: Remarkable progress has been achieved over the past 2 years in understanding the cellular actions of renalase, its pathophysiology and potential therapeutic utility. RECENT FINDINGS: There has been a paradigm shift in our thinking about the mechanisms underlying the cellular actions of renalase. We now understand that, independent of its enzymatic properties, renalase functions as a signaling molecule, a cytokine that interacts with a yet-to-be identified plasma membrane receptor(s) to activate protein kinase B and the mitogen-activated protein kinase pathway. These signaling properties are critical to its cytoprotective effects. New information regarding renalase's enzymatic function as an α-nicotinamide adenine dinucleotide oxidase/anomerase will be reviewed. Lastly, we will discuss the association of certain single nucleotide polymorphisms in the renalase gene with type 1 diabetes and with ischemic stroke, and the clinical implications of these findings. SUMMARY: The consistent association of renalase single nucleotide polymorphisms and the development of type 1 diabetes is a great interest particularly because we now understand that renalase functions as a cytokine. Future work on renalase should focus on exploring the identity of its receptor(s), and its potential role as an immune modulator.
Authors: Daria Sizova; Heino Velazquez; Benedita Sampaio-Maia; Janete Quelhas-Santos; Manuel Pestana; Gary V Desir Journal: Am J Physiol Renal Physiol Date: 2013-07-17
Authors: Chris Wallace; Maxime Rotival; Jason D Cooper; Catherine M Rice; Jennie H M Yang; Mhairi McNeill; Deborah J Smyth; David Niblett; François Cambien; Laurence Tiret; John A Todd; David G Clayton; Stefan Blankenberg Journal: Hum Mol Genet Date: 2012-03-08 Impact factor: 6.150
Authors: Joanna M M Howson; Jason D Cooper; Deborah J Smyth; Neil M Walker; Helen Stevens; Jin-Xiong She; George S Eisenbarth; Marian Rewers; John A Todd; Beena Akolkar; Patrick Concannon; Henry A Erlich; Cécile Julier; Grant Morahan; Jørn Nerup; Concepcion Nierras; Flemming Pociot; Stephen S Rich Journal: Diabetes Date: 2012-08-13 Impact factor: 9.461
Authors: Brett A Beaupre; Joseph V Roman; Matthew R Hoag; Kathleen M Meneely; Nicholas R Silvaggi; Audrey L Lamb; Graham R Moran Journal: Arch Biochem Biophys Date: 2016-10-18 Impact factor: 4.013
Authors: Xiaojia Guo; Shlomit Jessel; Rihao Qu; Yuval Kluger; Tian-Min Chen; Lindsay Hollander; Robert Safirstein; Bryce Nelson; Charles Cha; Marcus Bosenberg; Lucia B Jilaveanu; David Rimm; Carla V Rothlin; Harriet M Kluger; Gary V Desir Journal: Eur J Cancer Date: 2022-02-24 Impact factor: 9.162
Authors: Xiaojia Guo; Leyuan Xu; Heino Velazquez; Tian-Min Chen; Ryan M Williams; Daniel A Heller; Barbara Burtness; Robert Safirstein; Gary V Desir Journal: J Am Soc Nephrol Date: 2021-12-17 Impact factor: 10.121
Authors: Lindsay Hollander; Xiaojia Guo; Heino Velazquez; John Chang; Robert Safirstein; Harriet Kluger; Charles Cha; Gary V Desir Journal: Cancer Res Date: 2016-05-09 Impact factor: 12.701
Authors: Magda Wiśniewska; Natalia Serwin; Violetta Dziedziejko; Małgorzata Marchelek-Myśliwiec; Barbara Dołęgowska; Leszek Domański; Kazimierz Ciechanowski; Krzysztof Safranow; Tomasz Gołębiowski; Andrzej Pawlik Journal: Int J Environ Res Public Health Date: 2021-06-10 Impact factor: 3.390